Cargando...
Abnormal alternative splicing promotes tumor resistance in targeted therapy and immunotherapy
Abnormally alternative splicing events are common hallmark of diverse types of cancers. Splicing variants with aberrant functions play an important role in cancer development. Most importantly, a growing body of evidence has supported that alternative splicing might play a significant role in the th...
Gardado en:
| Publicado en: | Transl Oncol |
|---|---|
| Main Authors: | , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
Neoplasia Press
2021
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8039720/ https://ncbi.nlm.nih.gov/pubmed/33774500 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.tranon.2021.101077 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|